Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
Trials. 2022 Jun 2;23(1):454. doi: 10.1186/s13063-022-06396-5.
Trials. 2022.
PMID: 35655286
Free PMC article.
Compared to the previous clinical trial that targeted FD-PDS, this trial will have an 8-week double-blind treatment period to investigate the effect of long-term mediation through comparison with the placebo group. TRIAL REGISTRATION: ClinicalTrials.gov NCT03825692 . ...
Compared to the previous clinical trial that targeted FD-PDS, this trial will have an 8-week double-blind treatment period to investigate th …
"It ain't over … till it's over!" Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic.
Holtmann G, Quigley EM, Shah A, Camilleri M, Tan VP, Gwee KA, Sugano K, Sollano JD, Fock KM, Ghoshal UC, Chen M, Dignass A, Cohen H.
Holtmann G, et al. Among authors: gwee ka.
J Gastroenterol Hepatol. 2020 Jul;35(7):1117-1123. doi: 10.1111/jgh.15133. Epub 2020 Jun 29.
J Gastroenterol Hepatol. 2020.
PMID: 32511791
Free PMC article.
Review.
Local health systems aim to contain the COVID-19 pandemic and hospitals and health-care providers rush to provide the capacity for a surge of COVID-19 patients. However, the short, medium-term, and long-term outcomes of patients with gastrointestinal (GI) diseases w …
Local health systems aim to contain the COVID-19 pandemic and hospitals and health-care providers rush to provide the capacity for a surge o …
Item in Clipboard
Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice.
Ho KY, Gwee KA, Cheng YK, Yoon KH, Hee HT, Omar AR.
Ho KY, et al. Among authors: gwee ka.
J Pain Res. 2018 Sep 20;11:1937-1948. doi: 10.2147/JPR.S168188. eCollection 2018.
J Pain Res. 2018.
PMID: 30288088
Free PMC article.
Review.
Celecoxib has a better lower-GI-tract tolerability profile than ns-NSAIDs plus a proton-pump inhibitor. In addition, the latest data suggest that long-term use of celecoxib 200 mg/day may be appropriate for patients at increased CV risk....
Celecoxib has a better lower-GI-tract tolerability profile than ns-NSAIDs plus a proton-pump inhibitor. In addition, the latest data suggest …
Item in Clipboard
Cite
Cite